IP Library Assignment 035383/0823
Patent Assignment
Reel/Frame 035383/0823

Assignment of Assignor's Interest

Recorded: 2015-04-10 Pages: 9
Assignor
ENZON PHARMACEUTICALS, INC.
Executed: 2013-10-24
Assignee
SANTARIS PHARMA A/S
FREMTIDSVEJ 3, HERSHOLM, DK2970, DENMARK
Covered Properties (5)
Oligomeric Compounds for the Modulation Hif-1ALPHA Expression
Patent: 7,737,264 →
Application: 10/407,807 →
Publication: US 2004/0096848
Oligomeric Compounds for the Modulation of Hif-1ALPHA Expression
Patent: 7,846,911 →
Application: 12/580,126 →
Publication: US 2010/0093839
Oligomeric Compounds for the Modulation of Hif-1A Expression
Patent: 8,207,140 →
Application: 12/913,173 →
Publication: US 2011/0224285
Oligomeric Compounds for the Modulation of Hif-1A Expression
Patent: 8,357,670 →
Application: 13/477,825 →
Publication: US 2012/0270924
Oligomeric Compounds for the Modulation of Hif-1A Expression
Patent: 8,785,617 →
Application: 13/725,540 →
Publication: US 2013/0116309
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 27, 2003
From: THRUE, CHARLOTTE ALBACK; HOG, ANJA MOLHART; KRISTJANSEN, PAUL E.G.
To: SANTARIS PHARMA A/S
Reel/Frame 014639/0220 →
Assignment of Assignor's Interest Jul 23, 2007
From: SANTARIS PHARMA A/S
To: ENZON PHARMACEUTICALS, INC
Reel/Frame 019589/0108 →
Assignment of Assignor's Interest Oct 18, 2010
From: THRUE, CHARLOTTE ALBAEK; HOG, ANJA MOLHART; KRISTJANSEN, PAUL E.G.
To: SANTARIS PHARMA A/S
Reel/Frame 025154/0605 →
Assignment of Assignor's Interest Oct 18, 2010
From: SANTARIS PHARMA A/S
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 025154/0710 →
Merger and Change of Name Apr 13, 2015
From: SANTARIS PHARMA A/S; ROCHE INNOVATION CENTER COPENHAGEN A/S
To: ROCHE INNOVATION CENTER COPENHAGEN A/S
Reel/Frame 035421/0435 →